Experts largely hailed Walmart's rumored acquisition of Medicare Advantage provi...
Lawmakers are growing less optimistic about a full-reauthorization for PEPFAR, t...
AstraZeneca appeared to play down speculation about CEO Pascal Soriot after a U....
Some two years after splitting biotech company Bluebird Bio into two entities, t...
Hunting for the next Ozempic, dozens of companies are pursuing various combinati...
The FDA can’t fall for these five myths that often undermine health communications.
There’s a panel of 20 nutrition experts that has outsized influence on the Ameri...
Want to know which drugs could soon compete with Wegovy or Mounjaro? The STAT Ob...
The FDA issued new guidelines clarifying the way they plan to evaluate medical d...
Acelyrin, which raised more than $500 million in an IPO this year, ran into its ...
The FDA announced Monday that it had greenlit two updated Covid-19 booster shots...
President Biden’s nominee to lead NIH will get a hearing next month, perhaps tha...
As kids, they underwent a common test for UTIs. As adults, it haunts them as a t...
Cardiology is private equity’s latest fixation. Experts fear the financial inves...
Organized medicine in the United States has failed to meet its moment.
Janssen has filed a marketing authorisation application with the European Medici...
